Physician profile
Christopher Mark Englert
NPI 1922118538
$2,277.09
in general payments reported to CMS, 2019-2025
33 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $125 · 2021: $357 · 2022: $469 · 2023: $293 · 2024: $559 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $510.12 | 2020-2024 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $303.31 | 2021-2025 | Nuzyra |
| Horizon Therapeutics Plc | $211.11 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $176.33 | 2020-2025 | Puraply, Novachor |
| Nevro Corp. | $155.48 | 2024 | Senza |
| Kerecis Limited | $103.12 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $81.84 | 2021-2023 | Xarelto |
| Kci USA, INC. | $74.60 | 2020-2023 | V.A.C. Dermatac, Kerramax Care, Activ.A.C. |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.22 | 2022 | |
| Convatec INC. | $49.65 | 2023-2024 | |
| W. L. Gore & Associates, INC. | $47.29 | 2021 | |
| Bioventus LLC | $37.55 | 2019-2022 | |
| Integra Lifesciences Corporation | $31.99 | 2021-2022 | |
| Averitas Pharma INC. | $30.48 | 2025 | Qutenza |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $25.97 | 2021 | |
| Cardinal Health 200 LLC | $24.94 | 2019 | |
| Polarityte, INC. | $23.87 | 2019 | |
| Lemaitre Vascular, INC. | $23.32 | 2025 | Restoreflow |
| Silk Road Medical, INC. | $23.11 | 2021 | |
| Biowound Solutions, INC. | $22.45 | 2025 | Bio-Connekt |
| Baxter Healthcare | $19.88 | 2023 | Preveleak |
| Solventum Corporation | $16.77 | 2024 | Kerramax Care, Activ.A.C. |
| Heron Therapeutics, INC. | $16.74 | 2022 | |
| Mvp Orthopedics INC | $15.15 | 2021 | |
| Inari Medical, INC. | $14.51 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acera Surgical, INC. | $14.39 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.46 | 2025 | Exparel |
| Wright Medical Technology, INC. | $13.07 | 2019 | |
| Merck Sharp & Dohme LLC | $11.69 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $11.62 | 2022 | |
| Aroa Biosurgery Incorporated | $10.35 | 2022 | |
| Reprise Biomedical, INC. | $7.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Englert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.